Top Markets
Coin of the day
Epigenomics AG Epigenomics AG

Epigenomics AG

ECX
Classificação em ações #38936
Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a... Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a molecular diagnostics company dedicated to the early detection of cancer through liquid biopsy methods. Its primary offering, Epi proColon, is a blood-based assay specifically developed for the early identification of colorectal cancer, distributed across the United States, Europe, and China. The company's portfolio further encompasses a blood test for hepatocellular carcinoma and Epi BiSKit, a pre-analytical solution providing reagents essential for preparing bisulfite-converted DNA. Epigenomics' research and development initiatives are focused on pinpointing relevant biomarkers in human tissue and subsequently creating and securing patents for associated in vitro diagnostic blood tests.
Preço da ação
$0.83030862
Última sincronização: 2024-06-27
Valor de mercado
$726.64K
Variação (1 dia)
-1.35%
Variação (1 ano)
0.00%
País
DE
Negociar Epigenomics AG (ECX)

Categoria

Histórico de preços das ações de Epigenomics AG (ECX)
Preço de fecho mais alto: $1.42 em 2024-06-01

Preço de fecho mais baixo: $761.72 em 2014-09-01
Histórico de preços das ações da Epigenomics AG de 2014 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2024 -40.31%
2023 -70.25%
2022 -39.44%
2021 -83.30%
2020 -68.68%
2019 -24.83%
2018 -54.25%
2017 -3.39%
2016 90.76%
2015 -58.46%
2014 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$592.67 22.19%
US
$203.74 -3.08%
US
$23.08 67.91%
CN
$309.55 95.37%
US
$561.65 -14.11%
US